Cargando…
Removal of peptidoglycan and inhibition of active cellular processes leads to daptomycin tolerance in Enterococcus faecalis
Daptomycin is a cyclic lipopeptide antibiotic used in the clinic for treatment of severe enterococcal infections. Recent reports indicate that daptomycin targets active cellular processes, specifically, peptidoglycan biosynthesis. Within, we examined the efficacy of daptomycin against Enterococcus f...
Autores principales: | Johnston, Rachel D., Woodall, Brittni M., Harrison, Johnathan, Campagna, Shawn R., Fozo, Elizabeth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301656/ https://www.ncbi.nlm.nih.gov/pubmed/34297729 http://dx.doi.org/10.1371/journal.pone.0254796 |
Ejemplares similares
-
Induction of Daptomycin Tolerance in Enterococcus faecalis by Fatty Acid Combinations
por: Brewer, William, et al.
Publicado: (2020) -
Enterococcus faecalis Readily Adapts Membrane Phospholipid Composition to Environmental and Genetic Perturbation
por: Woodall, Brittni M., et al.
Publicado: (2021) -
Enterococcus faecalis and pathogenic streptococci inactivate daptomycin by releasing phospholipids
por: Ledger, Elizabeth V. K., et al.
Publicado: (2017) -
602. Mechanism of LiaY-Mediated Daptomycin Resistance in Enterococcus faecalis
por: Nguyen, April, et al.
Publicado: (2019) -
Peptidoglycan O-acetylation increases in response to vancomycin treatment in vancomycin-resistant Enterococcus faecalis
por: Chang, James D., et al.
Publicado: (2017)